no statement of use filed
on 31 May 2021
Last Applicant/ Owned by
170 Park Avenue
Florham Park
NJ
07932
Serial Number
88641502 filed on 03rd Oct 2019
Registration Number
N/A
Correspondent Address
Camille M. Miller
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of two "CC's" intersecting in the middle with the tips of the "C's" in teal blending to blue as moving toward the center of the "C's" blending to purple as continue to move toward the middle of the "C's" and intersecting at lilac and then blending back to purple and then blue and then to teal as proceed to other end of the "C's", and to the left of the intersection of the "C's" iRead More
Cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, placental tissue for use in scientific, laboratory and medical research; bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research; human amniotic membrane and human chorionic membrane for use in scientific, laboratory and medical research; human collagen and extracellular matrix compositions for use in scientific, laboratory and medical research; biological preparations for use in scientific, laboratory and medical research; biological products for use in scientific, laboratory and medical research, namely, placental-derived natural killer cells
Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; providing website featuring information in the field of medical research relating to banking stem cells and cord blood banking; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use, namely, for the treatment of cancer and other diseases, namely, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, namely, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
No 88641502
No Service Mark
No CLTY-0002US/
No
No
No
No
No
No
No
No
The mark consists of two "CC's" intersecting in the middle with the tips of the "C's" in teal blending to blue as moving toward the center of the "C's" blending to purple as continue to move toward the middle of the "C's" and intersecting at lilac and then blending back to purple and then blue and then to teal as proceed to other end of the "C's", and to the left of the intersection of the "C's" is the word "CELULARITY" in grey.
| Status Date | Action Taken |
|---|---|
| 01st Jun 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 31st May 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 21st Oct 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Oct 2020 | EXTENSION 1 GRANTED |
| 19th Oct 2020 | EXTENSION 1 FILED |
| 19th Oct 2020 | TEAS EXTENSION RECEIVED |
| 08th Oct 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 08th Oct 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 08th Oct 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 28th Apr 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
